The concept has been in use at the University of Washington, Seattle to advance open source software development for over 20 years, and was further developed by a grant from the Ewing Marion Kauffman Foundation (Kansas City) to help expand its use.
Kuldip K. Ahluwalia refined NVDC over the past 7 years to survive two episodes of MDS/AML leukemia and two bone marrow transplants. The key concept behind NVDC is a keen collaboration amongst physicians and commercial partners to focus on helping the patient survive rather than maintaining commercial interests. If adopted, this methodology has the potential to save patient lives with a keen focus on patients rather than commercial interests.
Glioblastoma is an aggressive malignant brain tumor with poor prognosis. Glioblastoma is incurable and very little progress has been made to augment the survival rate of patients with glioblastoma over the past 40 years. There is an urgent need to accelerate medical therapies for glioblastoma.
Neurosurgeons from institutions like Mayo Clinic, University of Louisville, Loma Linda University have expressed interest in joining in a collaborative effort to improve patient outcomes for brain tumors such as glioblastoma by sharing the knowledge learned from one patient and applying it to the next.